Search alternatives:
significantly elevated » significantly greater (Expand Search), significantly correlated (Expand Search), significantly decreased (Expand Search)
elevated decrease » elevated depressive (Expand Search), estimated decrease (Expand Search), greater decrease (Expand Search)
significantly elevated » significantly greater (Expand Search), significantly correlated (Expand Search), significantly decreased (Expand Search)
elevated decrease » elevated depressive (Expand Search), estimated decrease (Expand Search), greater decrease (Expand Search)
-
381
-
382
-
383
-
384
Ozone-Induced Alterations in Rhizospheric Nitrogen Pools and Their Implications for N<sub>2</sub>O Emissions in Rice Soil
Published 2025“…<p>Elevated tropospheric ozone (O<sub>3</sub>) may alter nitrous oxide (N<sub>2</sub>O) emissions from rice soils by affecting soil nitrogen pools and microbial activity. …”
-
385
-
386
-
387
Data Sheet 1_Dual variants of uncertain significance in a case of hyper-IgM syndrome: implications for diagnosis and management.pdf
Published 2025“…Background<p>Hyper-IgM syndrome (HIGM) is a genetic immunodeficiency characterized by elevated to normal IgM levels and decreased IgG, IgA, and IgE. …”
-
388
-
389
-
390
-
391
-
392
-
393
-
394
-
395
The original plotting data for Fig 7.
Published 2024“…PCOS rats displayed disrupted estrous cycles, increased weight, elevated serum testosterone, cystic follicles, granulosa cell layer thinning, and reduced corpora lutea count (<i>P</i> are all less than 0.05). …”
-
396
Primer sequences used for the qRT-PCR analysis.
Published 2024“…PCOS rats displayed disrupted estrous cycles, increased weight, elevated serum testosterone, cystic follicles, granulosa cell layer thinning, and reduced corpora lutea count (<i>P</i> are all less than 0.05). …”
-
397
Discovery of an Orally Active PDE1 Inhibitor for Disease-Modifying Treatment of Postmenopausal Osteoporosis via Dual Anabolic-Antiresorptive Mechanisms
Published 2025“…Postmenopausal osteoporosis (PMO) is characterized by an imbalance in bone remodeling with increased osteoclast and decreased osteoblast activity, leading to bone loss and higher fracture risk. …”
-
398
Discovery of an Orally Active PDE1 Inhibitor for Disease-Modifying Treatment of Postmenopausal Osteoporosis via Dual Anabolic-Antiresorptive Mechanisms
Published 2025“…Postmenopausal osteoporosis (PMO) is characterized by an imbalance in bone remodeling with increased osteoclast and decreased osteoblast activity, leading to bone loss and higher fracture risk. …”
-
399
Discovery of an Orally Active PDE1 Inhibitor for Disease-Modifying Treatment of Postmenopausal Osteoporosis via Dual Anabolic-Antiresorptive Mechanisms
Published 2025“…Postmenopausal osteoporosis (PMO) is characterized by an imbalance in bone remodeling with increased osteoclast and decreased osteoblast activity, leading to bone loss and higher fracture risk. …”
-
400
Study selection flow diagram.
Published 2025“…</p><p>Conclusions</p><p>Although age alone should not preclude nonagenarians from undergoing cardiac surgery, the procedure is associated with a significantly elevated risk of morbidity and a relatively high mortality rate. …”